ArticleMolecular therapy : the journal of the American Society of Gene Therapy2023
Distortion of journal impact factors in the era of paper mills.
Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Reply to Singer: Strike paper mills at the root.Proceedings of the National Academy of Sciences of the United States of America · 2025Article
- Identifying common patterns in journals that retracted papers from paper mills: a cross-sectional study.Research integrity and peer review · 2025Article
- The entities enabling scientific fraud at scale are large, resilient, and growing rapidly.Proceedings of the National Academy of Sciences of the United States of America · 2025Article
- Large-scale falsification of research papers risks public trust in biomedical sciences.Molecular therapy : the journal of the American Society of Gene Therapy · 2024Article
- ChatGPT and Corporations of Mega-journals Jeopardize the Norms That Underpin Academic Publishing.Archives of Iranian medicine · 2024Article
- The Molecular Therapy family of journals continues to lead the field of gene and cell therapy.Molecular therapy : the journal of the American Society of Gene Therapy · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.